Back
OncoCyte Vs. Fonar Industry Stock Comparison
Sell
28
OCX
OncoCyte
Last Price:
3.00
Seasonality Move:
-0.82%
Buy
57
FONR
Fonar
Last Price:
17.39
Seasonality Move:
9.19%
Sell
28
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.97. The Score for OCX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Fonar (FONR)
is a Buy
Is Fonar a Buy, Sell or Hold?
- The current Fonar [FONR] share price is $17.35. The Score for FONR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- FONR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FONR Stock Price Chart
OCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -3777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
FONR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 57.41 | Buy |
Chaikin Money Flow: | -4512 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
OCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.08 | Sell |
20-day SMA: | 3.11 | Sell |
50-day SMA: | 3.13 | Sell |
200-day SMA: | 2.98 | Sell |
8-day EMA: | 3.06 | Sell |
20-day EMA: | 3.09 | Sell |
50-day EMA: | 3.07 | Sell |
200-day EMA: | 3.34 | Sell |
FONR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.95 | Buy |
20-day SMA: | 16.95 | Buy |
50-day SMA: | 17.24 | Buy |
200-day SMA: | 18.34 | Sell |
8-day EMA: | 17.1 | Buy |
20-day EMA: | 16.98 | Buy |
50-day EMA: | 16.96 | Buy |
200-day EMA: | 17.38 | Sell |
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Fonar Earnings Growth & FONR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
OncoCyte Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fonar Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |